Browse By Viral Diseases
This page shows data for Lassa fever disease.
Total
Entries Retrieved: 1
| ID | Vaccine Name | Disease Name | Disease Classification | Virus Name | Nucleic Acid Content | Vaccine Type | Vaccine Status | Manufacturer | Year of Manufacturing | Manufacturing Country | Age | Dosage | Administration Route | Adjuvant | Target Strain | Description | Approving Organisation | Collaborating Organisation | Other Countries | Trade Name | PMID | Clinical Trial ID | Reference Link | Additional Links |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10212 | MV-LASV (V182-001) | Lassa fever | Hemorrhagic | Lassa virus | negative-sense, single-stranded RNA | Live-attenuated | Phase 1 | Themis Bioscience | 2021 | Belgium | 18 - 55 years | 2 doses 28 days apart | Intramuscular | NA | Measles Schwarz virus strain for prophylaxis of Lassa infection | NA | NA | NA | NA | NA | NA | NCT04055454 | https://clinicaltrials.gov/ct2/show/NCT04055454?cond=Lassa+fever&draw=2&rank=10 | NA |